TORI STORMER: Open Payments
NPI 1427585389 · PORT MATILDA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,660 in 112 payments from 15 companies in 2025. Trend: 2023 $3,338 · 2024 $3,932 · 2025 $1,660
Food & beverage: $1,660
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 15 | $272 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 25 | $207 |
| ABBVIE INC. | 13 | $161 |
| Collegium Pharmaceutical, Inc. | 11 | $146 |
| E.R. Squibb & Sons, L.L.C. | 10 | $145 |
| Neurocrine BioSciences, Inc. | 8 | $135 |
| Alkermes, Inc. | 5 | $116 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $108 |
| Lundbeck LLC | 5 | $95 |
| Supernus Pharmaceuticals, Inc. | 4 | $86 |
Products named: REXULTI, CAPLYTA, VRAYLAR, Jornay PM, COBENFY, INGREZZA, ABILIFY MAINTENA, TRINTELLIX.
Industry payments across PA — which companies pay providers there.
